Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a correction. Please see:

Correction: Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach - October 01, 2021

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach

Online download statistics by month:

Online download statistics by month: October 2021 to March 2024

	Abstract	Full	Pdf
Oct 2021	886	895	281
Nov 2021	342	343	89
Dec 2021	189	189	68
Jan 2022	134	140	53
Feb 2022	146	150	53
Mar 2022	182	189	89
Apr 2022	94	96	40
May 2022	98	98	41
Jun 2022	125	130	42
Jul 2022	113	115	32
Aug 2022	108	112	39
Sep 2022	116	118	57
Oct 2022	123	124	31
Nov 2022	82	83	37
Dec 2022	56	57	26
Jan 2023	43	45	36
Feb 2023	108	108	43
Mar 2023	92	93	22
Apr 2023	60	60	19
May 2023	75	77	24
Jun 2023	71	71	14
Jul 2023	45	45	18
Aug 2023	82	82	29
Sep 2023	46	46	18
Oct 2023	93	94	40
Nov 2023	94	94	21
Dec 2023	239	239	36
Jan 2024	67	68	29
Feb 2024	63	63	20
Mar 2024	94	95	93
Total	4066	4119	1440